Unique ID issued by UMIN | UMIN000006963 |
---|---|
Receipt number | R000008220 |
Scientific Title | The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis. |
Date of disclosure of the study information | 2011/12/27 |
Last modified on | 2014/06/27 15:55:31 |
The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.
Renal function is sustained by renal anemia inprovement using Nesp.- Juntendo
(REFRAIN -J study)
The effect of intervention with darbepoetin alfa on progression of renal decline[chronic renal failure?] in renal anaemia patients with chronic kidney disease not on dialysis.
Renal function is sustained by renal anemia inprovement using Nesp.- Juntendo
(REFRAIN -J study)
Japan |
renal anaemia patients with chronic kidney disease not on dialysis
Nephrology |
Others
NO
The object is to investigate the impact on progression of renal decline for darbepoetin alfa,when maintaining it to Hb 11g/dL or more in renal anaemia patients with chronic kidney disease not on dialysis.
Safety,Efficacy
Confirmatory
Pragmatic
Not applicable
Change in kidney function after two years
(The changes in renal function after darbepoetin alfa treatment)
1.Changes of biochemical makers in sera
2.Stratification comparison by inspection items (level of Hb and eGFR)
**Stratified analyses using baseline Hb level and doses of darbepoetin alfa
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
Darbepoetin alfa is administered to renal anaemia patients with chronic kidney disease not on dialysis and it maintains it to Hb value 11g/dL or more.
20 | years-old | <= |
Not applicable |
Male and Female
*Patients with chronic kidney disease not on dialysis.[Non-dialysis CKD patients]
*Patients with renal anemia, their levels of Hb are less than 11g/dL
*20 years of age and older
*Patient without renal anemia
*Patient having hypersensitivity to rHuEPO.
*Level of Hb is more than 13g/dL
*Patients with anemia caused by conditions other than renal anemia such as GI bleeding and blood desease
*Patients with serious allergies or serious drug sensitivities
*Patients with severe complications
*Pregnant or possibly pregnant and lactaing women
*Ineligible patients according to the investigator's judgment
200
1st name | |
Middle name | |
Last name | Yasuhiko Tomino |
Department of Internal Medicine,juntendo University Faculty of Medicine
Division of Nephrology
2-1-1 Hongo,Bunkyo ward,Tokyo,Japan
03-5802-1065
1st name | |
Middle name | |
Last name | Chieko Hamada |
Department of Internal Medicine,juntendo University Faculty of Medicine
Division of Nephrology
2-1-1 Hongo,Bunkyo ward,Tokyo,Japan
03-5802-1065
chieko@juntendo.ac.jp
Division of Nephrology,Department of Internal Medicine,Juntendo University Faculty of Medicine
Juntendo Clinical Research Center, Juntendo University Faculty of Medicine
Other
NO
順天堂大学医学部附属順天堂医院
2011 | Year | 12 | Month | 27 | Day |
Unpublished
Completed
2011 | Year | 06 | Month | 01 | Day |
2011 | Year | 07 | Month | 01 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2015 | Year | 12 | Month | 31 | Day |
2011 | Year | 12 | Month | 27 | Day |
2014 | Year | 06 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008220